Objectives

  1. Ascertain Myocardial Viability ln Ischemic Cardiomyopathy: (ICM) Reexamining Results From STICH and EVIVED-BCIS-2 Clinical Trials
  2. Balance Benefits and Risks of CABG or PCI Versus GLDM Therapy In ICM Patients with Demonstrable Myocardial Viability

Speaker: Julio Panza MD

 

Session date: 
05/01/2024 - 12:00pm to 1:00pm EDT
Location: 
Boston University Medical Center
72 E. Concord Street
Collamore 8
Boston, MA 02118
United States
  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 Participation

Please login or register to take this course.